Chi-Kuan Chen

711 total citations
16 papers, 497 citations indexed

About

Chi-Kuan Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chi-Kuan Chen has authored 16 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Chi-Kuan Chen's work include Cancer, Hypoxia, and Metabolism (4 papers), Liver physiology and pathology (2 papers) and Lymphatic System and Diseases (2 papers). Chi-Kuan Chen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Liver physiology and pathology (2 papers) and Lymphatic System and Diseases (2 papers). Chi-Kuan Chen collaborates with scholars based in Taiwan, United States and China. Chi-Kuan Chen's co-authors include Ming‐Hsien Chien, Kuo‐Tai Hua, Michael Hsiao, Wei-Jiunn Lee, Shun‐Fa Yang, Min‐Liang Kuo, Jen-Liang Su, Hung-Cheng Lai, Kenneth P. Nephew and Yi-Te Yo and has published in prestigious journals such as Blood, Hepatology and Scientific Reports.

In The Last Decade

Chi-Kuan Chen

16 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi-Kuan Chen Taiwan 13 311 161 140 66 38 16 497
Haoran Tang China 12 382 1.2× 169 1.0× 103 0.7× 49 0.7× 45 1.2× 29 577
Shengjun Xiao China 16 391 1.3× 165 1.0× 155 1.1× 82 1.2× 52 1.4× 41 631
Kaiqun Ren China 20 561 1.8× 152 0.9× 164 1.2× 106 1.6× 51 1.3× 36 760
Liansheng Gong China 14 306 1.0× 235 1.5× 112 0.8× 40 0.6× 39 1.0× 29 519
Bingxue Shang China 11 318 1.0× 126 0.8× 123 0.9× 82 1.2× 44 1.2× 17 594
Xueting Shao China 8 194 0.6× 82 0.5× 100 0.7× 105 1.6× 25 0.7× 14 443
Anna Gajos-Michniewicz Poland 14 504 1.6× 183 1.1× 168 1.2× 100 1.5× 52 1.4× 18 650

Countries citing papers authored by Chi-Kuan Chen

Since Specialization
Citations

This map shows the geographic impact of Chi-Kuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Kuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Kuan Chen more than expected).

Fields of papers citing papers by Chi-Kuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi-Kuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Kuan Chen. The network helps show where Chi-Kuan Chen may publish in the future.

Co-authorship network of co-authors of Chi-Kuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chi-Kuan Chen. A scholar is included among the top collaborators of Chi-Kuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi-Kuan Chen. Chi-Kuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Chi‐Long, et al.. (2019). Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach. Molecular Diagnosis & Therapy. 23(5). 645–656. 6 indexed citations
2.
Chen, Chi-Kuan, et al.. (2019). Finger-powered agglutination lab chip with CMOS image sensing for rapid point-of-care diagnosis applications. Lab on a Chip. 20(2). 424–433. 19 indexed citations
3.
Yang, Yi-Chieh, Ming‐Hsien Chien, Hsin-Yi Liu, et al.. (2018). Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress. Cancer Letters. 421. 28–40. 60 indexed citations
4.
Hung, Wen-Yueh, Jer‐Hwa Chang, Yu Cheng, et al.. (2018). Leukocyte Cell-Derived Chemotaxin 2 Retards Non-Small Cell Lung Cancer Progression Through Antagonizing MET and EGFR Activities. Cellular Physiology and Biochemistry. 51(1). 337–355. 13 indexed citations
5.
Chen, Chi-Kuan, Kuo‐Tai Hua, Pei Yu, et al.. (2016). Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells. Cancer Letters. 383(2). 282–294. 41 indexed citations
6.
Chen, Chi-Kuan, Wen-Hsuan Yu, Tsu‐Yao Cheng, et al.. (2016). Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis. Scientific Reports. 6(1). 31398–31398. 24 indexed citations
7.
Lin, Kai‐Min, Chung‐Wu Lin, Chi‐Long Chen, et al.. (2016). Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients’ survival. Blood. 128(12). 1578–1589. 19 indexed citations
8.
Lin, Chih‐Yang, Guan‐Ting Liu, Yen‐Ling Chen, et al.. (2016). CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells. Oncotarget. 7(24). 36896–36908. 32 indexed citations
9.
Chow, Jyh-Ming, Yi‐Hsien Hsieh, Chi-Kuan Chen, et al.. (2015). Tricetin suppresses the migration/invasion of human glioblastoma multiforme cells by inhibiting matrix metalloproteinase-2 through modulation of the expression and transcriptional activity of specificity protein 1. Expert Opinion on Therapeutic Targets. 19(10). 1293–1306. 26 indexed citations
10.
Hua, Kuo‐Tai, Wei-Jiunn Lee, Shun‐Fa Yang, et al.. (2013). Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(2). 387–397. 23 indexed citations
11.
Chen, Chi-Kuan, Ching‐Yao Yang, Kuo‐Tai Hua, et al.. (2013). Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment. Hepatology. 59(3). 974–985. 45 indexed citations
12.
Yo, Yi-Te, Yu-Chi Wang, Curt Balch, et al.. (2012). Growth Inhibition of Ovarian Tumor–Initiating Cells by Niclosamide. Molecular Cancer Therapeutics. 11(8). 1703–1712. 105 indexed citations
13.
Li, Chi–Rong, Michael T. Lee, Chi-Kuan Chen, et al.. (2012). Molecular Profiling of Prostatic Acinar Morphogenesis Identifies PDCD4 and KLF6 as Tissue Architecture–Specific Prognostic Markers in Prostate Cancer. American Journal Of Pathology. 182(2). 363–374. 9 indexed citations
14.
Kao, Shang-Jyh, Jen-Liang Su, Chi-Kuan Chen, et al.. (2012). Osthole inhibits the invasive ability of human lung adenocarcinoma cells via suppression of NF-κB-mediated matrix metalloproteinase-9 expression. Toxicology and Applied Pharmacology. 261(1). 105–115. 57 indexed citations
15.
Chen, Chi-Kuan, et al.. (2006). Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 450(2). 215–219. 3 indexed citations
16.
Lien, Wen‐Hui, et al.. (2004). Participation of cyclin D1 deregulation in TNP-470-mediated cytostatic effect: involvement of senescence. Biochemical Pharmacology. 68(4). 729–738. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026